The AI platform for drug discovery and development

Using AI to model the human body at a molecular level, CytoReason is delivering drugs faster and more effectively and revolutionizing the trillion dollar drug development landscape. CytoReason is trusted by 5 of the top 10 pharma companies.

Investment Opportunities

OurCrowd’s experienced investment team identifies and conducts rigorous research on thousands of companies and venture funds to tap into cutting-edge opportunities across sectors and stages. 

Join us to access these opportunities to invest alongside OurCrowd and other VCs.


“If anything kills over 10 million people in the next few decades, it’s most likely to be a highly infectious virus rather than a war – not missiles, but microbes. Part of the reason is we have invested a huge amount in nuclear deterrents, but we’ve actually invested very little in a system to stop an epidemic.”

-Bill Gates

 

INVEST IN 3 EASY STEPS

Join the OurCrowd platform, create a FREE investor account (accredited investors only). 

Browse investment opportunities, review due diligence material.

Invest and receive quarterly updates on your portfolio’s progress.

1 | JOIN

2 | BROWSE

3 | INVEST

CREATE A FREE ACCOUNT

OurCrowd is a global venture investing platform that empowers institutions and individuals to invest and engage in emerging companies. The most active venture investor in Israel, OurCrowd vets and selects companies, invests its capital, and provides its global network with unparalleled access to co-invest and contribute connections, talent and deal flow. OurCrowd builds value for its portfolio companies throughout their lifecycles, providing mentorship, recruiting industry advisors, navigating follow-on rounds and creating growth opportunities through its network of multinational partnerships.  

With $1.4 billion of committed funding, and investments in 200 portfolio companies and 22 venture funds, OurCrowd offers access to its membership of 45,000 individual accredited and institutional investors, family offices, and venture capital partners from over 183 countries to invest alongside, at the same terms.  OurCrowd’s portfolio is diversified across sectors and stages, ranging from seed and Series A through late stage and pre-IPO firms. Since its founding in 2013, OurCrowd portfolio companies have been acquired by some of the most prestigious brands in the world, including Uber, Canon, Oracle, Nike, and Intel. 

Learn More About OurCrowd

OurCrowd is a global venture investing platform that empowers institutions and individuals to invest and engage in emerging companies. The most active venture investor in Israel, OurCrowd vets and selects companies, invests its capital, and provides its global network with unparalleled access to co-invest and contribute connections, talent and deal flow. OurCrowd builds value for its portfolio companies throughout their lifecycles, providing mentorship, recruiting industry advisors, navigating follow-on rounds and creating growth opportunities through its network of multinational partnerships.  

With $1.4 billion of committed funding, and investments in 200 portfolio companies and 22 venture funds, OurCrowd offers access to its membership of 45,000 individual accredited and institutional investors, family offices, and venture capital partners from over 183 countries to invest alongside, at the same terms.  OurCrowd’s portfolio is diversified across sectors and stages, ranging from seed and Series A through late stage and pre-IPO firms. Since its founding in 2013, OurCrowd portfolio companies have been acquired by some of the most prestigious brands in the world, including Uber, Canon, Oracle, Nike, and Intel. 

Learn More About OurCrowd

OurCrowd portfolio companies have been acquired by 

Join for Free to Learn More About CytoReason
OurCrowd

As seen on

JOIN FOR FREE

INVEST IN 3 EASY STEPS

Join by creating a 
FREE investor account 
(accredited investors only). 

Browse investment opportunities, review due diligence material.

Invest and receive quarterly updates on your portfolio’s progress.

1 | JOIN

2 | BROWSE

3 | INVEST

JOIN FOR FREE
Launchpad optimizes the creation of complex, 3D-printed products combining multiple materials – enabling firms to innovate faster, more economically, and with onshore production.
Learn moreWatch the video
Scroll down ⬇︎
CytoReason is developing AI platform powered by proprietary pharmaceutical data to open up new opportunities to treat rare diseases.
Learn moreWatch the video
OurCrowd

Sayata delivers a streamlined solution for processing cyber policies. Increase profitability with an easy and intuitive platform.

Learn moreWatch the video

$1.8B

COMMITTED FUNDS

14,200+

COMPANIES VETTED

255+

PORTFOLIO COMPANIES

27

VENTURE FUNDS

5

INCUBATORS

159

FUND PORTFOLIO COMPANIES

46

EXITS

93,500

ACCREDITED INVESTORS

195

COUNTRIES REPRESENTED

JOIN FOR FREE